Sionc Pharmaceuticals Private Limited, a active private limited company, was established on 01 February 2008 in Visakhapatnam, Andhra Pradesh, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24232AP2008PTC057417. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹13.00 Cr and a paid-up capital of ₹12.15 Cr.
It upholds a compliant status. Employing 324 professional, Its leadership includes Manikreddy Pullagurla (Director), Srikanth Dandamudi (Director), Subba Rao Jetti (Director). Past directors included Manikreddy Pullagurla, Srikanth Dandamudi, Subba Rao Jetti. It holds ₹133.78 Cr open charges and ₹59.73 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 43-11-56 Subbalakshmi Nagar, Visakhapatnam, Andhra Pradesh, 530016.
U24232AP2008PTC057417
057417
01 February 2008
₹13.00 Cr
₹12.15 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Sionc Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manikreddy Pullagurla | Director | 21 May 2009 | Current |
| Srikanth Dandamudi | Director | 21 May 2009 | Current |
| Subba Rao Jetti | Director | 01 Dec 2011 | Current |
| Baburao Dandamudi | Managing Director | 01 Feb 2008 | Current |
| Jagadeesh Babu Rangisetty | Director | 01 Feb 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2010 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2010 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sionc Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.68% increase. The company also saw a substantial improvement in profitability, with a 66.34% increase in profit. The company's net worth Soared by an impressive increase of 22.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sionc Pharmaceuticals had a promoter holding of 37.91% and a public holding of 62.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,337,822,000.00
₹597,300,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2025 | Hdfc Bank Limited | ₹2.70 M | Open |
| 20 Sep 2024 | Others | ₹30.00 Cr | Open |
| 14 Mar 2023 | Hdfc Bank Limited | ₹2.97 M | Open |
| 25 Nov 2022 | Hdfc Bank Limited | ₹3.35 M | Open |
| 25 Nov 2021 | Hdfc Bank Limited | ₹102.88 Cr | Open |
Explore comprehensive loan charge details -
Sionc Pharmaceuticals has a workforce of 324 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sionc Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sionc Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.27 Cr with Charge ID 101072229 was registered on 29 Mar 2025. was documented.
Sionc Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 30.00 Cr with Charge ID 100985566 was registered on 20 Sep 2024. was documented.
Sionc Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was recorded as a recent event.
A charge with Hdfc Bank Limited of Rs. 102.88 Cr registered on 25 Nov 2021 with Charge ID 100513982 was modified on 25 Jan 2024. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 100688679 was registered on 14 Mar 2023. was completed.
The CIN of Sionc Pharmaceuticals Private Limited is U24232AP2008PTC057417.
Sionc Pharmaceuticals Private Limited is headquartered at 43-11-56 Subbalakshmi Nagar, Visakhapatnam, Andhra Pradesh, 530016.
Sionc Pharmaceuticals Private Limited was incorporated on 01 February 2008.
The current directors of Sionc Pharmaceuticals Private Limited are
The primary industry of Sionc Pharmaceuticals Private Limited is Manufacturing.
Sionc Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sionc Pharmaceuticals Private Limited is ₹13.00 Cr, and the paid-up capital is ₹12.15 Cr.
The compliance status of Sionc Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX